Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.24)
# 2,779
Out of 5,072 analysts
334
Total ratings
39.03%
Success rate
-2.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $53.30 | +50.09% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $72.66 | +3.22% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $82.70 | -21.40% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $7.64 | +83.25% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $5.52 | +1,711.59% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $30.46 | +47.73% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $27.50 | +172.73% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $22.03 | +36.18% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $17.82 | +146.91% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $20.95 | -52.27% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $24.41 | -59.03% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.52 | +252.11% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $11.98 | +943.41% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $18.55 | -19.14% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.11 | +350.45% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $7.68 | -34.90% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.22 | +18.48% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $9.63 | +55.76% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.99 | +114.39% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.40 | +25.00% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.60 | +426.32% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.72 | +308.16% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $3.80 | -21.05% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.54 | +270.37% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.62 | +455.56% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.15 | +191.26% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $3.14 | +2,195,222,829.94% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.31 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $53.30
Upside: +50.09%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $72.66
Upside: +3.22%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $82.70
Upside: -21.40%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $7.64
Upside: +83.25%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $5.52
Upside: +1,711.59%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $30.46
Upside: +47.73%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $27.50
Upside: +172.73%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $22.03
Upside: +36.18%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $17.82
Upside: +146.91%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $20.95
Upside: -52.27%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $24.41
Upside: -59.03%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $8.52
Upside: +252.11%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $11.98
Upside: +943.41%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $18.55
Upside: -19.14%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.11
Upside: +350.45%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $7.68
Upside: -34.90%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.22
Upside: +18.48%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $9.63
Upside: +55.76%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.99
Upside: +114.39%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.40
Upside: +25.00%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.60
Upside: +426.32%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.72
Upside: +308.16%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $3.80
Upside: -21.05%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.54
Upside: +270.37%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.62
Upside: +455.56%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.15
Upside: +191.26%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $3.14
Upside: +2,195,222,829.94%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $5.31
Upside: -